Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesSafety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09
Lakshman M et al. – Testosterone gels are as efficacious as patches and injectable forms in their effects on sexual function and mood. Anticipated increases in prostate–specific antigen with testosterone therapy are not significantly different with testosterone gels, and the risk of polycythemia is ower than injectable modalities. Application site reactions, a major drawback of testosterone patches, occur less frequently with testosterone gels. However, inter–personal transfer is a concern if appropriate precautions are not taken. Superior tolerability and dose flexibility make testosterone gel highly desirable over other modalities of testosterone replacement. Androgel and Testim, the two currently available testosterone gel products in the US, have certain brandspecific properties that clinicians may consider prior to prescribing.
Related Articles
Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets
European Journal of Endocrinology, 11/17/09
Relevance Score: 67%
Hypogonadism Risk in Men Treated for Childhood Cancer
Internet Source, 11/05/09
Relevance Score: 67%
Is androgen therapy indicated for aging men?
Sexuality, Reproduction & Menopause, 10/05/09
Relevance Score: 67%
Do male lymphoma survivors have impaired sexual function?
Journal of Clinical Oncology, 10/29/09
Relevance Score: 66%
Hypogonadism Risk in Men Treated for Childhood Cancer
Journal of Clinical Endocrinology and Metabolism, 10/12/09
Relevance Score: 66%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US
Current Medical Research and Opinion, 11/20/09
Metformin associated with lower cancer mortality in type 2 diabetes (ZODIAC-16)
Diabetes Care, 11/20/09
Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin
Current Medical Research and Opinion, 11/20/09
Sponsor
Article Search
Sponsor